Abstract:Key points Vascular dysfunction has been demonstrated in lowlanders at high-altitude (>4,000 m), however the extent of impairment and the delineation of contributing mechanisms have remained unclear. Using the gold-standard isolated perfused forearm model, we determined the extent of vasodilatory dysfunction and oxidative stress as a contributing mechanism in healthy lowlanders before and 4–6 days after rapid ascent to 4,300 m. The total forearm blood flow response to acetylcholine at high-altitude was decreased by ∼30%. Co-infusion of acetylcholine with the antioxidant vitamin C partially restored the total forearm blood flow by ∼20%. The magnitude of forearm blood flow reduction, as well as the impact of oxidative stress, was positively associated with the individual severity of hypoxemia. These data extend our basic understanding of vascular (mal)adaptation to high-altitude sojourn, with important implications for understanding the etiology of high-altitude related changes in endothelial-mediated vasodilatory function. High-altitude induced hypoxemia is often associated with peripheral vascular dysfunction; however, the basic mechanism(s) underlying high-altitude vascular impairments remains unclear. This study tested the hypothesis that oxidative stress contributes to the impairments in endothelial function during early acclimatization to high-altitude. Ten young healthy lowlanders were tested at sea-level (344 m) and following 4–6 days at high-altitude (4,300 m). Vascular endothelial function was determined using the isolated perfused forearm technique with forearm blood flow (FBF) measured by strain-gauge venous occlusion plethysmography. FBF was quantified in response to acetylcholine (ACh), sodium nitroprusside (SNP), and co-infusion of ACh with the antioxidant vitamin C (ACh+VitC). The total FBF response to ACh (area under the curve) was ∼30% lower at high-altitude compared to sea-level (P = 0.048). There was no difference in the response to SNP at high-altitude (P = 0.860). At sea-level, co-infusion of ACh+VitC had no influence on the FBF dose response (P = 0.268); however, at high-altitude ACh+VitC resulted in an average increase in the FBF dose response by ∼20% (P = 0.019). At high-altitude, the decreased FBF response to ACh, and the increase in FBF in response to ACh+VitC, were associated with the magnitude of arterial hypoxemia (R 2 = 0.60, P = 0.008 and R 2 = 0.63, P = 0.006, respectively). Collectively, these data support the hypothesis that impairments in vascular endothelial function at high-altitude are in part attributable to oxidative stress, consequent of the magnitude of hypoxemia. These data extend our basic understanding of vascular (mal)adaptation to high-altitude sojourn, with important implications for understanding the etiology of high-altitude related vascular dysfunction. This article is protected by copyright. All rights reserved

Effect of ubiquinol on electrophysiology during high-altitude acclimatization and de-acclimatization: A substudy of the Shigatse CARdiorespiratory fitness (SCARF) randomized clinical trial

Electrocardiographic changes during exercise in acute hypoxia and susceptibility to severe high-altitude illnesses

Short-term ubiquinol supplementation reduces oxidative stress associated with strenuous exercise in healthy adults: A randomized trial

Electrocardiographic signs of cardiac ischemia at rest and during exercise in patients with COPD travelling to 3100 m. Data from a randomized trial of acetazolamide.

GLOBAL REACH 2018: Intra‐arterial vitamin C improves endothelial‐dependent vasodilatory function in humans at high altitude

ECG changes at rest and during exercise in lowlanders with COPD travelling to 3100 m

Ubiquinol supplementation modulates energy metabolism and bone turnover during high intensity exercise

Product of Traditional Chinese Medicine Longgui Yangxinwan Protects the Human Body from Altitude Sickness Damage by Reducing Oxidative Stress and Preventing Mitochondrial Dysfunction

Left Ventricular Function During Acute High-Altitude Exposure in a Large Group of Healthy Young Chinese Men.

Carbon Monoxide-Saturated Hemoglobin-Based Oxygen Carriers Attenuate High-Altitude-Induced Cardiac Injury by Amelioration of the Inflammation Response and Mitochondrial Oxidative Damage.

Effects of short-term exposure to high altitude on cardiac function

Cardiovascular System Response to Carbon Dioxide and Exercise in Oxygen-Enriched Environment at 3800 m

Ubiquinol Ameliorates Endothelial Dysfunction in Subjects with Mild-to-Moderate Dyslipidemia: A Randomized Clinical Trial

Insights into the pharmacodynamics and pharmacokinetics of meldonium after exposure to acute high altitude

Ubiquinol Supplementation Alters Exercise Induced Fatigue by Increasing Lipid Utilization in Mice

Protective Effect of a Chronic Hypobaric Hypoxic Environment at High Altitude on Cardiotoxicity Induced by Doxorubicin in Rats: a 7 T Magnetic Resonance Study.

Metabolite Modulation in Human Plasma in the Early Phase of Acclimatization to Hypobaric Hypoxia

Myocardial mitochondrial oxidative stress and dysfunction in intense exercise: regulatory effects of quercetin

Cardiac autonomic regulation following a 246-km mountain ultra-marathon: An observational study

Cardioprotective effects of high-altitude adaptation in cardiac surgical patients: a retrospective cohort study with propensity score matching

Remote Ischemic Conditioning Improves Attention Network Function and Blood Oxygen Levels in Unacclimatized Adults Exposed to High Altitude